title: Extended indications for placement of an inferior vena cava filter.
abstract: To study the morbidity and mortality rates after placement of an inferior vena cava filter and to define the appropriate indications for interruption of the inferior vena cava, the records of all patients who underwent insertion of a Greenfield filter during the decade January 1978 to December 1987 were reviewed. Patients were designated as having either a traditional or extended indication for placement of an inferior vena cava filter. Two hundred sixty inferior vena cava filters were placed in 264 attempts, with no deaths related to insertion of the filter. An extended indication was the primary reason for placement of the Greenfield filter in 66 (25%) of the patients. In patients with extended indications there were no cases of air embolism or filter misplacement and only three wound complications (4.5%). Pulmonary embolism after insertion of the inferior vena cava filter occurred in three patients (4.5%), with one fatality (1.5%). Inferior vena cava occlusion was documented in three cases (4.5%), and manifestations of the postphlebitic syndrome in early follow-up were present in two patients (3.0%). As the procedures to prevent fatal pulmonary embolism have become safer, more efficacious, and less morbid, the number of patients in whom the potential benefits of insertion of an inferior vena cava filter outweigh the risks has become larger. Our results support the liberalized use of Greenfield filters in those patients who do not necessarily have one of the traditional indications for placement of an inferior vena cava filter but are at a high risk of having a fatal pulmonary embolus.
authors.affiliation: Division of Vascular Surgery, University of Massachusetts Medical School, Worcester 01655.
authors.forename: M J
authors.initials: MJ
authors.lastname: Rohrer
authors.forename: M G
authors.initials: MG
authors.lastname: Scheidler
authors.forename: H B
authors.initials: HB
authors.lastname: Wheeler
authors.forename: B S
authors.initials: BS
authors.lastname: Cutler
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005374:Filtration / Q000295:instrumentation*; D006801:Humans; D007431:Intraoperative Complications / Q000209:etiology; D011183:Postoperative Complications / Q000209:etiology; D011655:Pulmonary Embolism / Q000517:prevention & control*; D012307:Risk Factors; D013924:Thrombophlebitis / Q000517:prevention & control; D013997:Time Factors; D014682:Vena Cava, Inferior
chemical_list: D000925:Anticoagulants